Showing results (281-290 of 757) with videos related to
Sort By:
Pageof 76
Circulation. Cardiovascular Genetics|January 8, 2014
Gene mutations versus clinically relevant phenotypes: lyso-Gb3 defines Fabry diseaseMarkus Niemann, Arndt Rolfs, Stefan Störk, et al.International Journal of Molecular Sciences|April 3, 2021
Characterization of Extracellular Vesicles from Preconditioned Human Adipose-Derived Stromal/Stem CellsAlec Geßner, Benjamin Koch, Kevin Klann, et al.Blood Purification|February 14, 2015
Extracorporeal virus elimination for the treatment of severe Ebola virus disease--first experience with lectin affinity plasmapheresisStefan Büttner, Benjamin Koch, Olga Dolnik, et al.The American Journal of Emergency Medicine|February 18, 2010
Optimization of initial energy for cardioversion of atrial tachyarrhythmias with biphasic shocksJohann Reisinger, Christine Gstrein, Thomas Winter, et al.Heart (British Cardiac Society)|May 12, 2011
Low homoarginine concentration is a novel risk factor for heart diseaseStefan Pilz, Andreas Meinitzer, Andreas Tomaschitz, et al.European Heart Journal|September 11, 2019
Relationship between hypoglycaemia, cardiovascular outcomes, and empagliflozin treatment in the EMPA-REG OUTCOME® trialDavid Fitchett, Silvio E Inzucchi, Christoph Wanner, et al.The Lancet. Diabetes & Endocrinology|July 2, 2017
Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trialDavid Z I Cherney, Bernard Zinman, Silvio E Inzucchi, et al.Scientific Reports|August 27, 2020
Risk factors for retinopathy in hemodialysis patients with type 2 diabetes mellitusMichael Müller, Carl-Ludwig Schönfeld, Tanja Grammer, et al.Kidney International|March 1, 2016
Long-term effects following 4 years of randomized treatment with atorvastatin in patients with type 2 diabetes mellitus on hemodialysisVera Krane, Kay-Renke Schmidt, Lena J Gutjahr-Lengsfeld, et al.Journal of Inherited Metabolic Disease|April 15, 2024
Genetic variants of unknown significance in alpha-galactosidase A: Cellular delineation from Fabry diseaseAlexandra Klein, Katharina Klug, Maximilian Breyer, et al.Pageof 76